AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02680132 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nexium 40 mg DR Capsules of AstraZeneca LP, USA
Description: oral, cross over
Study NCT02680132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Torrent's Esomeprazole Magnesium DR Capsules 40 mg
Description: oral, cross over
Study NCT03574753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABBV-399
Description: ABBV-399 (Process II), 2.7 mg/kg IV over 30 ± 10 minutes, Day 1, Every 21 days
Study NCT01274663 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-05175157 or Placebo
Description: One dose of PF-05175157 will be administered as a powder-in-capsule in the fasting state in the AM; correspondingly, one dose of a matched powder-in-capsule placebo will be administered in the fasting state in the AM.
Study NCT01274663 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-05175157 or Placebo
Description: One dose of PF-05175157 will be administered as a powder-in-capsule immediately after breakfast; correspondingly, one dose of a matched powder-in-capsule placebo will be administered immediately after breakfast.
Study NCT04234165 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TURBT
Description: different power sources ( bipolar vs monopolar)
Study NCT04234165 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TURBT
Description: different power sources ( bipolar vs monopolar)
Study NCT03853720 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: balloon-occluded retrograde transvenous and endoscopic obliteration of high-risk gastric varices
Description: Catheterization of the left renal vein and the inferior diaphragmatic vein and occlusion with a balloon placed in the distal portion of this vein.~Endoscopic access to the gastric cavity, gastric varices identification and flow measurement, including velocity, by endoscopic Doppler ultrasound (US). The balloon in the draining vein will be inflated and the velocity will be reassessed. Endoscopic puncture of the varices will be done and the embolization will be conducted under balloon-occlusive conditions (Injection of Cyanoacrylate: Lipiodol mixture 1:1 slowly and gradually). Balloon will be kept inflated and a microcatheter will be used through its lumen inside the variceal bed to inject occlusive agent (cyanoacrylate) mixed with Lipiodol.~At the end of the procedure an occlusion device (plug amplatzer 2) will be placed.
Study NCT04491539 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Finding Respect and Ending Stigma around HIV (FRESH)
Description: The Finding Respect and Ending Stigma around HIV (FRESH) intervention is theoretically informed by Social Cognitive Theory (SCT) and Interpersonal Contact theory (ICT) and was specifically designed for delivery in high-stigma settings, such as Dominican Republic. FRESH was originally developed in Africa to address HIV-related stigma, and later was adapted to address intersectional stigmas experienced by sexual and gender minorities (SGM) living with HIV in the United States Deep South. To our knowledge, FRESH will be the first intervention to address intersectional stigmas experienced by men who have sex with men, transgender women, and people living with HIV in clinical settings in the Spanish-speaking Caribbean.
Study NCT04538872 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: StraDiMS implicit
Description: participants perform a goal-directed stepping task and try to react as fast as possible by stepping on a tile that lights up. Response time (the time between the tile lighting up and the participant stepping on the tile) is the outcome measure of the task. The implicit learning conditions and the explicit learning condition differ from each other in the instructions given prior to the task. The latter group will get more knowledge on the task than the former.
Study NCT04538872 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: StraDiMS implicit
Description: participants perform a goal-directed stepping task and try to react as fast as possible by stepping on a tile that lights up. Response time (the time between the tile lighting up and the participant stepping on the tile) is the outcome measure of the task. The implicit learning conditions and the explicit learning condition differ from each other in the instructions given prior to the task. The latter group will get more knowledge on the task than the former.
Study NCT04538872 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: StraDiMs explicit
Description: participants perform a goal-directed stepping task and try to react as fast as possible by stepping on a tile that lights up. Response time (the time between the tile lighting up and the participant stepping on the tile) is the outcome measure of the task. The implicit learning conditions and the explicit learning condition differ from each other in the instructions given prior to the task. The latter group will get more knowledge on the task than the former.
Study NCT04538872 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: StraDiMs explicit
Description: participants perform a goal-directed stepping task and try to react as fast as possible by stepping on a tile that lights up. Response time (the time between the tile lighting up and the participant stepping on the tile) is the outcome measure of the task. The implicit learning conditions and the explicit learning condition differ from each other in the instructions given prior to the task. The latter group will get more knowledge on the task than the former.
Study NCT00932360 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS
Description: Active TENS, Placebo TENS and No Treatment TENS
Study NCT01851642 — intervention group
Intervention type: PROCEDURE
Intervention: History and physical exam.
Description: At every study visit, participant's will be asked about their medical history and will have a physical exam.
Study NCT04687332 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Apheresis therapy by Octo Nova Technology (DIAMED, Cologne, Germany)
Description: One group was treated with IA and the single use tryptophan adsorber, the other group was treated with PE and the Plasmaflow (see above). In total, all patients receive 5 treatments.
Study NCT02510092 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous coronary intervention with new generation fully resorbable scaffold
Study NCT01651858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nurigra Chewable tablet
Description: 1 tablet of 100mg, once a day
Study NCT01651858 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nurigra Chewable tablet
Description: 1 tablet of 100mg, once a day
Study NCT03777540 — intervention group
Intervention type: PROCEDURE
Intervention: Gastric resection
Description: Partial gastrectomy with jejunal anastomosis, total gastrectomy, gastroenterostomy without gastrectomy or other (palliative surgery).
Study NCT00924105 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CYT013-IL1bQb
Description: s.c. injection
Study NCT00924105 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: s.c. injection
Study NCT04060082 — intervention group
Intervention type: OTHER
Intervention: Telephone Interview
Description: Participants will be asked to answer questions about their experiences with FTD.
Study NCT03256955 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Tof cuff
Description: The Tof Cuff will be installed on one arm. After anesthesia induction the Tof Cuff will be calibrated and continuos monitoring of the neuromuscular block started until complete recovery of neuromuscular block.
Study NCT03256955 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Tof Watch SX
Description: The Tof Watch SX will be installed on the opposite arm to the Tof Cuff. After anesthesia induction the Tof Watch SX will be calibrated and continuos monitoring of the neuromuscular block started until complete recovery of neuromuscular block.
Study NCT03041350 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smartphone video-assisted ALS(advanced life support)
Description: As an preparation for this study, personnel training in mock advanced life support (ALS) simulation including the smartphone video call methodology was conducted. The smartphones were not separately purchased or produced; commercially available smartphones already owned by the emergency medical service (EMS) personnel and medical directors were used. To facilitate the smartphone video call between the medical director and the EMS personnel and to prevent the caregivers or others nearby from hearing the conversation, Bluetooth earphone sets were used. Data were collected using the cardiopulmonary resuscitation (CPR) recording form uploaded in SNS which consisted of EMS personnel and medical directors, and the quality of CPR was evaluated
Study NCT03687073 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indole-3-Carbinol
Description: Cohorts 2, 3, \& 4: 400 mg PO BID
Study NCT03687073 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Silibinin
Description: Cohorts 1 \& 4: 720mg
Study NCT03687073 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Silibin
Description: Cohort 3: 360mg
Study NCT02067195 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Receiving hydration with a 1 mL/kg bolus of intravenous isotonic saline (0.9% sodium chloride)
Description: No hydration for patients without chronic kidney disease(CrCl\<60ml/min),or Receiving hydration with a 1 mL/kg bolus of intravenous isotonic saline (0.9% sodium chloride) after diagnosis of chronic kidney disease until 24 hours after PCI. Hydration rate was reduced to 0.5 mL/kg per hour in patients with New York Heart Association class III or KillipⅡ/Ⅲ.
Study NCT02067195 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3 mL/kg.hour bolus of intravenous isotonic saline (0.9% sodium chloride)
Description: Receiving hydration with a 3 mL/kg.hour bolus of intravenous isotonic saline (0.9% sodium chloride) from randomization to the end of the procedure, the measurement of LVEDP was conducted after the procedure, a sliding-scale hydration was employed in the LVEDP-guided hydration arm that was based on LVEDP for 2 hours: 5 ml/kg/hr for LVEDP \<13 mmHg, 3 ml/kg/hr for LVEDP 13-18 mmHg, and >1.5 ml/kg/hr for LVEDP >18 mmHg, whereas,0.5 ml/kg/hr for LVEDP >20 mmHg, continue hydration with a 1 mL/kg until 24 hours after procedure. Hydration rate was reduced to 0.5 mL/kg per hour in patients with New York Heart Association class III or KillipⅡ/Ⅲ.
Study NCT02513849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: Daily tamoxifen tablet for approximately 4 weeks
Study NCT04315194 — intervention group
Intervention type: DRUG
Intervention: clarithromycin-naproxen-oseltamivir
Description: to compare the safety and efficacy of clarithromycin-naproxen-oseltamivir combination therapy to that of oseltamivir treatment alone for hospitalised paediatric influenza patients.
Study NCT01829971 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRX34
Description: micro RNA therapy
Study NCT02602912 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Injeq Bioimpedance Probe (BIP) Needle
Description: Injeq Bioimpedance Probe (BIP) Needle is a spinal needle that has bioimpedance measurement capability. It consists of traditional needle cannulae and removable bioimpedance probe which enables the measurement of bioimpedance. The needle is connected to measurement device and tissue identifying algorithm. Bioimpedance is measured during the operation and the algorithm detects when the needle tip is in contact with cerebrospinal fluid.
Study NCT04190979 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medyria TrackCath System
Description: The TrackCath System is a non-implantable device and consists of the TrackCath Catheter and the TrackCath Equipment. It is designed to support the successful positioning of third-party guidewires and catheters in the arterial vasculature to detect and cannulate side branches during endovascular aneurysm repair procedures through the measurement of real-time blood flow velocity changes.
Study NCT06089148 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: contrast enhanced digital mammography, tomosyntheis and MRI
Study NCT03524885 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Short implant placement
Description: Ten patients will be randomly selected for the short implants option, 2 or 3 implant 4-5 mm length and 4 mm diameter (Syra Short, Sweden \& Martina, Padua, Italy) will be positioned. The healing cap will be immediately connected and a vycril suture will be done after soft tissue reflection.~After three months an acrylic screw-retained bridge will be delivered. After further three months, a definitive restauration with a metal ceramic bridge will be seated.
Study NCT03524885 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone regeneration with longer implants
Description: Ten patients will be randomly assigned to the regenerative group, 2 or 3 implant from 10 to 13 mm length intentionally exposed putting the implant platform 2 or 3 mm apical to CEJ of the adjacent tooth will be inserted.~A horizontal and vertical regeneration following GBR technique will be performed using not-resorbable PTFE titanium reinforced membrane (Cytoplast Osteogenics, US) fixed by titanium pins or miniscrews to ensure the perfect stability (Pro-fix, Cytoplast Osteogenics, US).
Study NCT02453373 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ThermoSuit Cooling Induction
Description: Rapid induction of therapeutic hypothermia (32-34 degrees C) using the Life Recovery Systems ThermoSuit System
Study NCT02453373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium Sulfate
Description: Magnesium sulfate will be administered intravenously as needed to control shivering
Study NCT02453373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tPA
Description: tPA will be administered intravenously if indicated
Study NCT02453373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Induction doses of propofol or etomidate will be used to aid in the suppression of patient discomfort
Study NCT02453373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etomidate
Description: Induction doses of propofol or etomidate will be used to aid in the suppression of patient discomfort
Study NCT02453373 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neurothrombectomy
Description: If indicated, neurothrombectomy will be performed using an FDA-cleared device within the FDA-cleared treatment window.
Study NCT02447055 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Study NCT02447055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Study NCT02447055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Study NCT02447055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Study NCT02447055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Study NCT02447055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Study NCT02447055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Filgrastim
Study NCT03105167 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cortical bone trajectory screws
Description: cortical bone trajectory screws fixation takes the place of traditional pedicle screws fixation will be used in transforaminal lumbar interbody fusion.
Study NCT03105167 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pedicle screws
Description: traditional pedicle screws fixation will be used in transforaminal lumbar interbody fusion.
Study NCT02453490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raltitrexed-based chemotherapy
Description: Raltitrexed: 2.0mg,iv,15min,d1,Oxaliplatin:85mg/m2 iv,d1, q2w
Study NCT02453490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raltitrexed-based chemotherapy
Description: Raltitrexed: 2.0mg,iv,15min,d1,Irinotecan:180mg/m2 iv,d1, q2w
Study NCT02453490 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-fluorouracil-based chemotherapy
Description: 5-fluorouracil:400mg/m2,ivp,2h,d1,1200mg/m2/d\*2d(2400mg/m2,iv46-48h); Oxaliplatin:85mg/m2 iv,d1,q2w
Study NCT02453490 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-fluorouracil-based chemotherapy
Description: 5-fluorouracil: 400mg/m2,ivp,2h,d1,1200mg/m2/d\*2d(2400mg/m2,iv46-48h); Irinotecan:180mg/m2 d1, iv,q2w
Study NCT03598647 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Affect and physical activity
Description: The focus of this intervention is to help the participant to become more aware of their positive feelings and experiences related to exercise. They will learn about typical affective responses to exercise, view their own affective responses to exercise, and they will be taught cognitive strategies for altering affective responses to exercise. Participants will also receive general information about exercise safety, physical activity guidelines, and exercise intensity.
Study NCT03598647 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity information
Description: Participants will receive general information about exercise safety, physical activity guidelines, and exercise intensity.
Study NCT00688155 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Training
Description: Two 1-hour center and two 15- to 45-minute home-based training sessions per week to include aerobic, strength, flexibility, and balance training for 6 months. The ultimate goal is to accumulate 150 minutes of walking per week between center and home-based sessions.
Study NCT00688155 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: Two 1-hour sessions per week for the first two months and then one 1-hour session per week for months 3-6.
Study NCT00688155 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Aging Education
Description: One 1-hour lecture each week for 3 months, then monthly.
Study NCT01971021 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PICC or subcutaneous venous port
Study NCT01496729 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transversus abdominis plane (TAP) block
Description: A Transversus abdominis plane (TAP) block with ropivacaine, a local anesthetic, will be performed at the end of the surgical procedure.
Study NCT01496729 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham TAP block with normal saline
Description: A sham TAP block with normal saline will be performed at the end of the surgical procedure.
Study NCT02905929 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ActivPAL inclinometer
Description: Participants will wear a thigh-worn inclinometer for the first 3 weeks of the intervention, and at the mid-point of the intervention. The device will monitor their sitting and standing time.
Study NCT02905929 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Phone counseling call: Breaking up sitting time
Description: Participants will receive 5 counseling phone calls to check-in on goal setting, strategies, and tools.
Study NCT02905929 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: In-person counseling: Breaking up sitting time
Description: Participants will receive 3 in-person health education sessions. At these sessions participants will receive feedback from the ActivPAL showing periods throughout the day where participants have been sitting. Participants will also develop action plans, check-in on goal setting, and use of tools at these sessions.
Study NCT02905929 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Phone counseling call: Healthy living
Description: Participants will receive a healthy living educational intervention over the phone, developed and tested by the investigators in previous studies. Participants will not receive any information on diet, physical activity or sedentary behavior that may affect the outcomes.
Study NCT02905929 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tools to prompt standing
Description: Investigators will provide standing desks to participants who spend time sitting at a computer. Additional tools to help prompt standing are mechanical and electronic timers set to interrupt long periods of sitting and cues in the environment such as standing during commercial breaks and phone calls.
Study NCT02905929 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: In-person counseling: Healthy living
Description: Control subjects will receive one in-person counseling session about healthy living. Participants will not receive any information on diet, physical activity or sedentary behavior that may affect the outcomes.
Study NCT03631030 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Cooled radiofrequency ablation
Description: Cooled Radiofrequency ablation (CRFA) is a well-established method for delivering lesions into nervous tissue to accomplish neurotomy procedures
Study NCT04334707 — intervention group
Intervention type: PROCEDURE
Intervention: Kidney Biopsy
Description: A kidney biopsy is a procedure that involves taking a small piece of kidney tissue for examination with a microscope. A licensed health care provider will perform a kidney biopsy.
Study NCT02484833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Study NCT02484833 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetuximab
Study NCT02484833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFIRI
Study NCT02484833 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFIRI